Effects of mometasone in children aged 4-9 years old with mild persistent asthma.
Phase of Trial: Phase II/III
Latest Information Update: 29 Nov 2011
At a glance
- Drugs Mometasone (Primary)
- Indications Asthma
- Focus Pharmacodynamics
- 29 Nov 2011 Primary endpoint 'Growth-rate' has been met.
- 05 Nov 2010 New trial record.